| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Medical Officer | Chief Medical Officer
1 company
Brazzell Romulus K is a See Remarks at KALA BIO, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $3K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | KALA Kala Bio, Inc. | See Remarks | Sell | 3,504 | $1.30 | $4,555.20 | -1.2% | +0.8% | -33.7% | |
| Oct 26, 2021 | KALA Kala Bio, Inc. | Chief Medical Officer | Sell | 12,757 | $1.80 | $22,962.60 | -4.2% | -51.8% | -93.0% | |
| Jun 28, 2021 | KALA Kala Bio, Inc. | Chief Medical Officer | Sell | 3,034 | $5.77 | $17,506.18 | -1.0% | -46.6% | -93.9% |